Raggruppamento Secondario: Distrofia Muscolare di Duchenne

Filtra

Data

EMG-based Indicators of Muscular Co-Activation during Gait in Children with Duchenne Muscular Dystrophy

Evaluation of gait in Duchenne Muscular Dystrophy: Relation of 3D gait analysis to clinical assessment

Comparison of the Gait Biomechanical Constraints in Three Different Type of Neuromotor Damages

A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy

Safety, tolerability and pharmacokinetics of eteplirsen in young boys aged 6-48 months with Duchenne muscular dystrophy amenable to exon 51 skipping

Prevalence of Duchenne muscular dystrophy in Italy: a nationwide survey

The relationship between deficit in digit span and genotype in nonsense mutation Duchenne muscular dystrophy

Ataluren treatment of patients with nonsense mutation dystrophinopathy.

Long-Term Safety and Efficacy Data of Golodirsen in Ambulatory Patients with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A First-in-human, Multicenter, Two-Part, Open-Label, Phase 1/2 Trial

Management of motor rehabilitation in individuals with muscular dystrophies. 1(st) Consensus Conference report from UILDM – Italian Muscular Dystrophy Association (Rome, January 25-26, 2019)

Torna in alto